<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Aβ1-42 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/a%ce%b21-42/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 16 Nov 2025 18:34:59 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Aβ1-42 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Microglial CARs Enhance Selective Phagocytosis of Aβ1-42</title>
		<link>https://bioengineer.org/microglial-cars-enhance-selective-phagocytosis-of-a%ce%b21-42/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 16 Nov 2025 18:34:36 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[Aβ1-42]]></category>
		<category><![CDATA[CAR Therapy]]></category>
		<category><![CDATA[microglia]]></category>
		<guid isPermaLink="false">https://bioengineer.org/microglial-cars-enhance-selective-phagocytosis-of-a%ce%b21-42/</guid>

					<description><![CDATA[In recent groundbreaking research, scientists led by Heiss, C.N., Riise, R., and Hanse, E., published an essential study that sheds light on the potential therapeutic strategies for Alzheimer’s disease. Their work explores the innovative concept of utilizing chimeric antigen receptors (CARs) engineered on microglia to enhance the phagocytosis of amyloid-beta peptides, specifically Aβ1-42, which are [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">297596</post-id>	</item>
	</channel>
</rss>
